Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma (original) (raw)

Accession codes

Primary accessions

Gene Expression Omnibus

Data deposits

Gene expression profiling data have been deposited in the Gene Expression Omnibus (GEO) under accession number GSE18817.

References

  1. Klein, G. & Klein, E. Conditioned tumorigenicity of activated oncogenes. Cancer Res. 46, 3211–3224 (1986)
    CAS PubMed Google Scholar
  2. Bahler, D. W. & Levy, R. Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proc. Natl Acad. Sci. USA 89, 6770–6774 (1992)
    Article ADS CAS Google Scholar
  3. Refaeli, Y. et al. The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas. PLoS Biol. 6, e152 (2008)
    Article Google Scholar
  4. Ngo, V. N. et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 441, 106–110 (2006)
    Article ADS CAS Google Scholar
  5. Lenz, G. et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319, 1676–1679 (2008)
    Article ADS CAS Google Scholar
  6. Reth, M. Antigen receptor tail clue. Nature 338, 383–384 (1989)
    Article ADS CAS Google Scholar
  7. Alizadeh, A. A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511 (2000)
    Article ADS CAS Google Scholar
  8. Staudt, L. M. & Dave, S. The biology of human lymphoid malignancies revealed by gene expression profiling. Adv. Immunol. 87, 163–208 (2005)
    Article CAS Google Scholar
  9. Davis, R. E., Brown, K. D., Siebenlist, U. & Staudt, L. M. Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J. Exp. Med. 194, 1861–1874 (2001)
    Article CAS Google Scholar
  10. Dal Porto, J. M. et al. B cell antigen receptor signaling 101. Mol. Immunol. 41, 599–613 (2004)
    Article CAS Google Scholar
  11. Chen, L. et al. SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. Blood 111, 2230–2237 (2008)
    Article CAS Google Scholar
  12. Tolar, P., Hanna, J., Krueger, P. D. & Pierce, S. K. The constant region of the membrane immunoglobulin mediates B cell-receptor clustering and signaling in response to membrane antigens. Immunity 30, 44–55 (2009)
    Article CAS Google Scholar
  13. Lam, K. P., Kuhn, R. & Rajewsky, K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90, 1073–1083 (1997)
    Article CAS Google Scholar
  14. Kraus, M., Alimzhanov, M. B., Rajewsky, N. & Rajewsky, K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igα/β heterodimer. Cell 117, 787–800 (2004)
    Article CAS Google Scholar
  15. Thome, M. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nature Rev. Immunol. 4, 348–359 (2004)
    Article CAS Google Scholar
  16. Gordon, M. S., Kanegai, C. M., Doerr, J. R. & Wall, R. Somatic hypermutation of the B cell receptor genes B29 (_Ig_β, CD79b) and mb1 (_Ig_α, CD79a). Proc. Natl Acad. Sci. USA 100, 4126–4131 (2003)
    Article ADS CAS Google Scholar
  17. Gazumyan, A., Reichlin, A. & Nussenzweig, M. C. Igβ tyrosine residues contribute to the control of B cell receptor signaling by regulating receptor internalization. J. Exp. Med. 203, 1785–1794 (2006)
    Article CAS Google Scholar
  18. Gauld, S. B. & Cambier, J. C. Src-family kinases in B-cell development and signaling. Oncogene 23, 8001–8006 (2004)
    Article CAS Google Scholar
  19. Chan, V. W., Meng, F., Soriano, P., DeFranco, A. L. & Lowell, C. A. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7, 69–81 (1997)
    Article CAS Google Scholar
  20. Niiro, H. et al. The B lymphocyte adaptor molecule of 32 kilodaltons (Bam32) regulates B cell antigen receptor internalization. J. Immunol. 173, 5601–5609 (2004)
    Article CAS Google Scholar
  21. Ma, H. et al. Visualization of Syk-antigen receptor interactions using green fluorescent protein: differential roles for Syk and Lyn in the regulation of receptor capping and internalization. J. Immunol. 166, 1507–1516 (2001)
    Article CAS Google Scholar
  22. Kraus, M., Saijo, K., Torres, R. M. & Rajewsky, K. Ig-α cytoplasmic truncation renders immature B cells more sensitive to antigen contact. Immunity 11, 537–545 (1999)
    Article CAS Google Scholar
  23. Torres, R. M. & Hafen, K. A negative regulatory role for Ig-α during B cell development. Immunity 11, 527–536 (1999)
    Article CAS Google Scholar
  24. Hantschel, O. et al. The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib. Proc. Natl Acad. Sci. USA 104, 13283–13288 (2007)
    Article ADS CAS Google Scholar
  25. Pan, Z. et al. Discovery of selective irreversible inhibitors for Bruton’s tyrosine kinase. ChemMedChem 2, 58–61 (2007)
    Article CAS Google Scholar
  26. Jin, S., DiPaola, R. S., Mathew, R. & White, E. Metabolic catastrophe as a means to cancer cell death. J. Cell Sci. 120, 379–383 (2007)
    Article CAS Google Scholar
  27. Lam, L. T. et al. Small molecule inhibitors of IκB-kinase are selectively toxic for subgroups of diffuse large B cell lymphoma defined by gene expression profiling. Clin. Cancer Res. 11, 28–40 (2005)
    Article CAS Google Scholar
  28. Lenz, G. et al. Stromal gene signatures in large-B-cell lymphomas. N. Engl. J. Med. 359, 2313–2323 (2008)
    Article CAS Google Scholar
  29. Blethrow, J., Zhang, C., Shokat, K. M. & Weiss, E. L. Design and use of analog-sensitive protein kinases. Curr. Protocols Mol. Biol. Unit 18.11 10.1002/0471142727.mb1811s66 (2004)
  30. Tolar, P., Sohn, H. W. & Pierce, S. K. The initiation of antigen-induced B cell antigen receptor signaling viewed in living cells by fluorescence resonance energy transfer. Nature Immunol. 6, 1168–1176 (2005)
    Article CAS Google Scholar
  31. Jiang, S. et al. Chemical genetic transcriptional fingerprinting for selectivity profiling of kinase inhibitors. Assay Drug Dev. Technol. 5, 49–64 (2007)
    Article CAS Google Scholar
  32. Stewart, D. M., Kurman, C. C. & Nelson, D. L. Production of monoclonal antibodies to Bruton’s tyrosine kinase. Hybridoma 14, 243–246 (1995)
    Article CAS Google Scholar

Download references

Acknowledgements

We thank L. Honigberg for PCI-32765, L. Dang for IKK-β inhibitors, S. Ansher for dasatinib, and S. Tohda for the TMD8 cell line. This research was supported by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute, the Center for Cancer Research, the National Institute of Allergy and Infectious Disease, and the National Human Genome Research Institute. P.B.R. was a Howard Hughes Medical Institute-National Institutes of Health Research Scholar.

Author Contributions R.E.D., V.N.N., G.L., P.T., R.M.Y., P.B.R., H.K., L.L. and A.L.S. designed and performed experiments. H.Z., Y.Y. and W.X. performed experiments. G.W., W.X. and J.P. analysed data. J.J. and C.J.T. synthesized reagents. A.R., G.O., H.K.M.-H., R.D.G., J.M.C., N.A.J., L.M.R., E.C., E.S.J., W.H.W., J.D., E.B.S., R.I.F., R.M.B., R.R.T., J.R.C., D.D.W. and W.C.C. supplied samples from patients and reviewed pathological and clinical data. S.K.P. supervised research. L.M.S. designed and supervised research and wrote the manuscript.

Author information

Author notes

  1. R. Eric Davis, Vu N. Ngo and Georg Lenz: These authors contributed equally to this work.

Authors and Affiliations

  1. Metabolism Branch,,
    R. Eric Davis, Vu N. Ngo, Georg Lenz, Ryan M. Young, Paul B. Romesser, Holger Kohlhammer, Laurence Lamy, Hong Zhao, Yandan Yang, Weihong Xu, Arthur L. Shaffer, Wyndham H. Wilson & Louis M. Staudt
  2. Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA ,
    Elaine S. Jaffe
  3. Laboratory of Immunogenetics, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland 20852, USA ,
    Pavel Tolar & Susan K. Pierce
  4. Howard Hughes Medical Institute – National Institutes of Health Research Scholars Program, Bethesda, Maryland 20892, USA ,
    Paul B. Romesser
  5. Division of Cancer Treatment and Diagnosis, Biometric Research Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA,
    George Wright
  6. Division of Computational Bioscience, Bioinformatics and Molecular Analysis Section, Center for Information Technology, National Institutes of Health, Bethesda, Maryland 20892, USA,
    Wenming Xiao & John Powell
  7. NIH Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland 20850, USA ,
    Jian-kang Jiang & Craig J. Thomas
  8. Department of Pathology, University of Würzburg, 97080 Würzburg, Germany
    Andreas Rosenwald & Hans Konrad Muller-Hermelink
  9. Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany
    German Ott
  10. British Columbia Cancer Agency, Vancouver, British Columbia, Canada V5Z 4E6 ,
    Randy D. Gascoyne, Joseph M. Connors & Nathalie A. Johnson
  11. Department of Pathology, University of Arizona, Tucson, Arizona 85724, USA,
    Lisa M. Rimsza
  12. Southwest Oncology Group, 24 Frank Lloyd Wright Drive, Ann Arbor, Michigan 48106, USA ,
    Lisa M. Rimsza, Richard I. Fisher, Rita M. Braziel, Raymond R. Tubbs & J. R. Cook
  13. Hospital Clinic, University of Barcelona, 08036 Barcelona, Spain
    Elias Campo
  14. Pathology Clinic, Rikshospitalet University Hospital, N-0310 Oslo, Norway
    Jan Delabie
  15. Faculty Division of the Norwegian Radium Hospital, Institute for Cancer Research, Rikshospitalet University Hospital and Center for Cancer Biomedicine, University of Oslo, N-0310 Oslo, Norway
    Erlend B. Smeland
  16. James P. Wilmot Cancer Center, University of Rochester School of Medicine, Rochester, New York 14642, USA ,
    Richard I. Fisher
  17. Oregon Health and Science University, Portland, Oregon 97239, USA ,
    Rita M. Braziel
  18. Cleveland Clinic Pathology and Laboratory Medicine Institute, Cleveland, Ohio 44195, USA ,
    Raymond R. Tubbs & J. R. Cook
  19. Departments of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198, USA,
    Dennis D. Weisenburger & Wing C. Chan

Authors

  1. R. Eric Davis
  2. Vu N. Ngo
  3. Georg Lenz
  4. Pavel Tolar
  5. Ryan M. Young
  6. Paul B. Romesser
  7. Holger Kohlhammer
  8. Laurence Lamy
  9. Hong Zhao
  10. Yandan Yang
  11. Weihong Xu
  12. Arthur L. Shaffer
  13. George Wright
  14. Wenming Xiao
  15. John Powell
  16. Jian-kang Jiang
  17. Craig J. Thomas
  18. Andreas Rosenwald
  19. German Ott
  20. Hans Konrad Muller-Hermelink
  21. Randy D. Gascoyne
  22. Joseph M. Connors
  23. Nathalie A. Johnson
  24. Lisa M. Rimsza
  25. Elias Campo
  26. Elaine S. Jaffe
  27. Wyndham H. Wilson
  28. Jan Delabie
  29. Erlend B. Smeland
  30. Richard I. Fisher
  31. Rita M. Braziel
  32. Raymond R. Tubbs
  33. J. R. Cook
  34. Dennis D. Weisenburger
  35. Wing C. Chan
  36. Susan K. Pierce
  37. Louis M. Staudt

Corresponding author

Correspondence toLouis M. Staudt.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

PowerPoint slides

Rights and permissions

About this article

Cite this article

Davis, R., Ngo, V., Lenz, G. et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.Nature 463, 88–92 (2010). https://doi.org/10.1038/nature08638

Download citation